Biontech stock.

Cash Amount. Record Date. Pay Date. Jun 2, 2022. $2.111. Jun 3, 2022. Jun 17, 2022. * Dividend amounts are adjusted for stock splits when applicable. Get the latest dividend data for BioNTech SE (BNTX), including dividend history, yield, key dates, growth and other metrics.BioNTech: The Novavax Fork In The Road. A high-level overview of BioNTech SE (BNTX) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools.On average, Wall Street analysts predict. that Biontech Se's share price could reach $113.57 by May 8, 2025. The average Biontech Se stock price prediction forecasts a potential upside of 23.37% from the current BNTX share price of $92.06.Aug 28, 2021 · That's why it's important to consider a stock like BioNTech (BNTX 1.59%). Sure, the stock has climbed 962% since the beginning of last year. Sure, the stock has climbed 962% since the beginning of ...

BioNTech. BioNTech SE ( / biːˈɒntɛk / bee-ON-tek; or / baɪˈɒntɛk / bye-ON-tek [2] short for Biopharmaceutical New Technologies) is a German biotechnology company based in Mainz that develops and manufactures active immunotherapies for patient-specific approaches to the treatment of diseases.BNTX Competitors. $ Market cap P/E ratio $ Price 1d change 52-week range. View BioNTech SE Sponsored ADR BNTX stock quote prices, financial information, real-time forecasts, and company news from CNN.BioNTech reported Q4 2023 earnings below expectations, with EPS at €1.90 vs. €9.26 last year. Sales were €1.479 billion, missing consensus. Guidance for 2024 anticipates revenues of €2.5 ...

BioNTech Q3 Profit Falls, Trims FY23 Vaccine Revenue Outlook. RTTNews. Nov. 6, 2023, 08:06 AM. (RTTNews) - BioNTech SE (BNTX) Monday announced a sharp fall in third-quarter earnings compared to ...BioNTech expects to release third-quarter results on Nov. 6. BioNTech's stock has dropped 31.1% year to date through Friday, while Pfizer shares have tumbled 37.3% and the S&P 500 has gained 12.7% ...

In depth view into BNTX (BioNTech) stock including the latest price, news, dividend history, earnings information and financials. ... BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including …Stock Information Stock Quote & Chart Stock Quote & Chart. Change ... BioNTech SE. An der Goldgrube 12. 55131 Mainz, Germany. T: +49 6131 9084-0. F: +49 6131 9084-2121.In addition, BioNTech SE Sponsored ADR has a VGM Score of D (this is a weighted average of the individual Style Scores which allow you to focus on the stocks that best fit your personal trading ...Stock analysis for BioNTech SE (22UA:Xetra) including stock price, stock chart, company news, key statistics, fundamentals and company profile.

Luz ultravioleta

Find the latest BioNTech SE (BNTX) stock discussion in Yahoo Finance's forum. Share your opinion and gain insight from other stock traders and investors.

The latest BioNTech stock prices, stock quotes, news, and BNTX history to help you invest and trade smarter. BioNTech expects to release third-quarter results on Nov. 6. BioNTech's stock has dropped 31.1% year to date through Friday, while Pfizer shares have tumbled 37.3% and the S&P 500 has gained 12.7% ...Complete BioNTech SE ADR stock information by Barron's. View real-time BNTX stock price and news, along with industry-best analysis.You can find more details about BioNTech stock by going to one of the sections listed on this page such as historical data, price charts, technical analysis and others. BNTX Scorecard. Fair Value. An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.BioNTech plans to initiate a pivotal Phase 2 trial in relapsed/refractory germ cell tumors in 2024. In 2024, BioNTech intends to accelerate the development of its portfolio of next-generation investigational medicines both as monotherapies and in combination with immunotherapy agents and other targeted therapies across a wide range of tumor types.May 7, 2024 · 5:53 AM. BioNTech (Filer) Form 6-K. Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934. (Data available from 1/1/2016 forward) This page (NASDAQ:BNTX) was last updated on 5/8/2024 by MarketBeat.com Staff. BioNTech shares have soared 171.6% year to date through Friday and Pfizer's stock has lost 7.1%, while the S&P 500 SPX, -0.14% has gained 8.6%. Advertisement Read Next

BioNTech SE (NASDAQ:BNTX) Q1 2024 Earnings Call Transcript. BioNTech SE (NASDAQ:BNTX) Q1 2024 Earnings Call Transcript May 6, 2024 BioNTech SE isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Welcome to BioNTech’s First Quarter 2024 Earnings Call.Because of that gap in time -- and the risk of failures during clinical trials -- determining whether BioNTech stock is a buy is less about valuation and more about the open-ended potential of a ...Still, the brothers are poised to lock in major gains after first providing BioNTech with €150 million ($186 million) in seed money when it was founded in 2008. The shares have climbed more than ...BioNTech SE: Delayed Quote, intraday chart, variations, volumes, technical indicators and last transactions, Stock BioNTech SE | Nasdaq: BNTX | NasdaqBioNTech: The Novavax Fork In The Road. A high-level overview of BioNTech SE (BNTX) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools.BioNTech SE (BNTX) As of 2:17 PM EDT. Market Open. Find the latest BioNTech SE (BNTX) stock quote, history, news and other vital information to help you with your stock trading and investing.

Why BioNTech Was a Sickly Stock This Week. Eric Volkman | Dec 30, 2022 The world is trying hard to get past the coronavirus pandemic, and investors are trying hard to get past coronavirus stocks.

Jan 14, 2024 ... 1. Market Sentiment and Vaccine Rollout Progress. As COVID-19 became less of a public health concern, the demand for vaccines in the market also ...Feb 20, 2024 · Insights from analysts' 12-month price targets are revealed, presenting an average target of $127.5, a high estimate of $171.00, and a low estimate of $99.00. This current average has decreased by ... BioNTech stock tumbled to its lowest point in three years Wednesday after the Covid vaccine maker reported light fourth-quarter sales and profit, and delivered lackluster 2024 guidance.. X. The ...BioNTech hit its lowest point in the month on Feb. 24 at $138.57. The stock has a 52-week low of $90.29 and a 52-week high of $464. Over the past 12 months, the stock is up more than 43%.Get the latest BioNTech SE - ADR (BNTX) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions.MAINZ, Germany, October 23, 2023 (GLOBE NEWSWIRE) – BioNTech SE (Nasdaq: BNTX, “BioNTech” or “the Company”) today announced follow-up data from its ongoing first-in-human Phase 1/2 trial (NCT04503278; 2019-004323-20) evaluating the safety and efficacy of the Company’s Claudin-6 (CLDN6)-directed CAR-T cell therapy candidate …On today's stock market, BNTX stock dipped 0.4% and closed at 108.05. BNTX Stock: Lower Boosting Levels Expected. The Pfizer -partnered Covid shot is BioNTech's only commercial product. BioNTech's ...Why BioNTech Was a Sickly Stock This Week. Eric Volkman | Dec 30, 2022 The world is trying hard to get past the coronavirus pandemic, and investors are trying hard to get past coronavirus stocks.The company affirmed its full-year guidance of revenue between EUR2.5 billion and EUR3.1 billion ($2.7 billion and $3.3 billion). BioNTech ADRs have lost about …

Slo motion

The company affirmed its full-year guidance of revenue between EUR2.5 billion and EUR3.1 billion ($2.7 billion and $3.3 billion). BioNTech ADRs have lost about …

BioNTech has agreed to buy UK artificial intelligence start-up InstaDeep for up to £562mn in its biggest-ever deal, as the German company expands beyond the Covid-19 vaccine that transformed its ...If you want to keep up to date on the stock market you have a device in your pocket that makes that possible. Your phone can track everything finance-related and help keep you up t...We at BioNTech believe that the immune system is the fundamental driver for therapeutic success in cancer, and infectious diseases and other serious diseases. As immune engineers we have a deep understanding of the underlying mechanisms that enable the immune system to effectively recognize both external threats like infectious diseases and …Get the latest information on BioNTech SE (BNTX), a German biotechnology company that develops mRNA-based vaccines and therapies. See its stock performance, financial results, news, analysis, …Stock analysis for BioNTech SE (BNTX:NASDAQ GS) including stock price, stock chart, company news, key statistics, fundamentals and company profile.BioNTech SE - ADR (22UA) Stock Price & News - Google Finance. Home 22UA • FRA. BioNTech SE - ADR. €83.05. Apr 30, 11:00:14 PM GMT+2 · EUR · FRA · Disclaimer. …BioNTech hit its lowest point in the month on Feb. 24 at $138.57. The stock has a 52-week low of $90.29 and a 52-week high of $464. Over the past 12 months, the stock is up more than 43%.May 10, 2024 · BioNTech’s stock sinks after earnings miss, as inventory writedowns weigh Mar. 20, 2024 at 7:30 a.m. ET by Tomi Kilgore Biontech 4Q Rev EUR1.48B

BioNTech SE is a Germany-based clinical-stage biotechnology company. The Company focuses on patient-specific immunotherapies for the treatment of cancer and other serious diseases. The Company is providing technologies includ ing mRNA-based therapies, cell therapies, small molecules and antibodies, which can be utilized for specific purposes or …Get the latest BioNTech SE - ADR (22UA) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions.On Thursday, BMO Capital Markets adjusted its outlook on BioNTech (NASDAQ: BNTX) shares, reducing the price target to $123 from the previous $127, while still maintaining an Outperform rating.The ...Instagram:https://instagram. samsung s13 Mainz, Germany, January 9, 2024 (GLOBE NEWSWIRE) -- BioNTech SE (Nasdaq: BNTX, “BioNTech” or “the Company”) provided its full year 2024 revenue guidance as part of its outlined 2024 ...Shares of BioNTech SE BNTX, +0.58% dropped 2.4% toward a three-month low in premarket trading Monday, after the Germany-based biotechnology company, which developed a COVID-19 vaccine with partner ... qc bank and trust BioNTech shares have soared 171.6% year to date through Friday and Pfizer's stock has lost 7.1%, while the S&P 500 SPX, -0.14% has gained 8.6%. Advertisement Read NextBioNTech SE is a Germany-based clinical-stage biotechnology company. The Company focuses on patient-specific immunotherapies for the treatment of cancer and other serious diseases. The Company is providing technologies including mRNA-based therapies, cell therapies, small molecules and antibodies, which can be utilized for specific … usa tv channel View BioNTech SE Sponsored ADR BNTX investment & stock information. Get the latest BioNTech SE Sponsored ADR BNTX detailed stock quotes, stock data, Real-Time ECN, charts, stats and more.BioNTech will hold an Innovation Series Day on Tuesday in Boston to offer analysts an update on its pipeline. The stock has fallen 36% in the year to date, while the S&P 500 has gained 13.5% ... va dominion bill pay MAINZ, Germany, and ROCKVILLE, Maryland, USA, June 29, 2023 (GLOBE NEWSWIRE) — BioNTech SE (Nasdaq: BNTX, “BioNTech”) and OncoC4, Inc. (“OncoC4”) today announced that the first patient with non-small cell lung cancer (NSCLC) has been treated in a pivotal Phase 3 trial evaluating the companies’ next-generation anti-CTLA-4 … audio a texto BioNTech SE is a Germany-based clinical-stage biotechnology company. The Company focuses on patient-specific immunotherapies for the treatment of cancer and other serious diseases. The Company is providing technologies includ ing mRNA-based therapies, cell therapies, small molecules and antibodies, which can be utilized for specific purposes or ... Find the latest BioNTech SE (22UA.F) stock quote, history, news and other vital information to help you with your stock trading and investing. kronos payroll Company profile page for BioNTech SE including stock price, company news, executives, board members, and contact information. BNTX Competitors. $ Market cap P/E ratio $ Price 1d change 52-week range. View BioNTech SE Sponsored ADR BNTX stock quote prices, financial information, real-time forecasts, and company news from CNN. indianapolis indiana to chicago The company affirmed its full-year guidance of revenue between EUR2.5 billion and EUR3.1 billion ($2.7 billion and $3.3 billion). BioNTech ADRs have lost about …NASDAQ: BNTX. BioNTech Se. Market Cap. $22B. Today's Change. (-0.44%) -$0.41. Current Price. $92.31. Price as of May 6, 2024, 10:51 a.m. ET. Or is it too … translation norwegian to english Complete BioNTech SE ADR stock information by Barron's. View real-time BNTX stock price and news, along with industry-best analysis.Discover real-time BioNTech SE American Depositary Share (BNTX) stock prices, quotes, historical data, news, and Insights for informed trading and investment decisions. Stay ahead with Nasdaq. russian to english The latest BioNTech stock prices, stock quotes, news, and BNTX history to help you invest and trade smarter. Monday, BioNTech SE (NASDAQ:BNTX) reported a first-quarter EPS loss of 1.31 euros ($1.41 loss), a shift from an income of 2.05 euros, missing the consensus loss of 97 cents. The COVID-19 vaccine ... point zero energy 4 days ago · 11 brokers have issued 12 month price targets for BioNTech's shares. Their BNTX share price targets range from $90.00 to $171.00. On average, they expect the company's stock price to reach $118.82 in the next year. This suggests a possible upside of 28.1% from the stock's current price. extract text from image Jan 9, 2024 · Get Biontech SE (BNTX.O) real-time stock quotes, news, price and financial information from Reuters to inform your trading and investments Chicken stock is good for around four days in the refrigerator after being opened or made. Homemade chicken stock does not last as long as store-bought stock. Chicken stock keeps b...